Baxter has issued a voluntary recall for one lot of its 70% Dextrose Injection due to the potential presence of stainless steel particulate matter. This recall highlights serious health risks, including blood vessel blockage, life-threatening pulmonary embolism, permanent organ damage, or even death, if the contaminated solution is administered intravenously.
The affected product was distributed to healthcare providers and distributors in Alabama, Georgia, and Tennessee between July 25, 2026, and July 28, 2026. As of August 25, 2026, Baxter has not received any reports of adverse events related to this issue. The injection is typically used as a caloric and fluid source, mixed with other fluids for patients requiring parenteral nutrition.
Consumers and healthcare providers are advised to immediately discontinue use and return all affected units. Homecare facilities that used this lot for compounding parenteral nutrition solutions should contact patients to replace their solutions. Baxter is contacting customers with return instructions, and consumers with questions can contact Baxter Healthcare Center for Service at 888-229-0001. The FDA encourages reporting adverse events to its MedWatch program.